These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35347521)

  • 1. Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews.
    Mercieca-Bebber R; Aiyegbusi OL; King MT; Brundage M; Snyder C; Calvert M
    Qual Life Res; 2022 Oct; 31(10):2939-2957. PubMed ID: 35347521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.
    Efficace F; Fayers P; Pusic A; Cemal Y; Yanagawa J; Jacobs M; la Sala A; Cafaro V; Whale K; Rees J; Blazeby J;
    Cancer; 2015 Sep; 121(18):3335-42. PubMed ID: 26079197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
    Calvert M; Blazeby J; Altman DG; Revicki DA; Moher D; Brundage MD;
    JAMA; 2013 Feb; 309(8):814-22. PubMed ID: 23443445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice.
    Mercieca-Bebber R; Friedlander M; Calvert M; Stockler M; Kyte D; Kok PS; King MT
    J Patient Rep Outcomes; 2017; 1(1):5. PubMed ID: 29757300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating The Reporting of Patient-Reported Outcomes in Surgical Management of Stress Urinary Incontinence in Women: An Analysis of Randomized Controlled Trials.
    Batioja K; Peña A; Smith C; Minley K; Wise A; Shepard S; Heigle B; Ottwell R; Hartwell M; Vassar M
    Womens Health Issues; 2023; 33(3):312-319. PubMed ID: 36443180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the underreporting of patient-reported outcomes in carpal tunnel syndrome randomized controlled trials.
    Ladd C; Jacobsen SM; Snider K; Bacani R; Hillman C; Shepard S; Heigle B; Ottwell R; Hartwell M; Vassar M
    J Osteopath Med; 2023 Jun; 123(6):301-308. PubMed ID: 36840430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.
    Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M
    J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underreporting of patient-reported outcomes in cystic fibrosis randomized controlled trials using CONSORT-PRO and RoB 2.0.
    Moore T; Nees D; Hightower B; Brock L; Kee M; Wise A; Heigle B; Ottwell R; Hartwell M; Vassar M
    Respir Med Res; 2023 Jun; 83():100962. PubMed ID: 36563550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials.
    Khan T; Khalid M; Dunford B; Nguyen T; Wise A; Heigle B; Shepard S; Kee M; Hillman C; Ottwell R; Hartwell M; Vassar M
    Mult Scler Relat Disord; 2022 Jul; 63():103819. PubMed ID: 35487036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.
    Chakraborty R; Cannella L; Cottone F; Efficace F
    Lancet Haematol; 2020 Dec; 7(12):e892-e901. PubMed ID: 33242446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of patient-reported outcomes amongst randomized clinical trials in plastic surgery: a systematic review using CONSORT-PRO.
    Milazzo T; Yuan M; Graham A; Kim P; Gallo L; Uhlman K; Thoma A; Coroneos C; Voineskos S
    J Plast Reconstr Aesthet Surg; 2024 Dec; 99():110-121. PubMed ID: 39368267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.
    Garnier L; Charton E; Falcoz A; Paget-Bailly S; Vernerey D; Jary M; Ducray F; Curtit E
    Neurooncol Pract; 2021 Apr; 8(2):148-159. PubMed ID: 33898048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting of patient-reported outcomes in trials on alcohol use disorder: a meta-epidemiological study.
    Douglas A; Garrett E; Staggs J; Williams C; Shepard S; Wise A; Hillman C; Ottwell R; Hartwell M; Vassar M
    BMJ Evid Based Med; 2023 Feb; 28(1):21-29. PubMed ID: 35470132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: how CONSORTed are the data?
    Pat K; Dooms C; Vansteenkiste J
    Lung Cancer; 2008 Oct; 62(1):126-38. PubMed ID: 18395928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
    Kumar S; Mohammad H; Vora H; Kar K
    J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of reporting and fragility index for randomized controlled trials in the vesicoureteral reflux literature: where do we stand?
    Gnech M; Lovatt CA; McGrath M; Rickard M; Sanger S; Lorenzo AJ; Braga LH
    J Pediatr Urol; 2019 May; 15(3):204-212. PubMed ID: 31060965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Reporting Completeness of Patient-Reported Outcomes in Esophageal Motility Disorders: A Cross-Sectional Analysis of Randomized Controlled Trials.
    Staggs J; Williams C; Love M; Renner A; Kee M; Hillman C; Shepard S; Heigle B; Rauh S; Ottwell R; Hartwell M; Vassar M
    Dysphagia; 2022 Dec; 37(6):1576-1585. PubMed ID: 35194671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.